Get the Stockscreener App
197.00
0.03%
-0.06
After Hours:
197.00
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cardinal Health Inc stock is traded at $197.00, with a volume of 1.36M.
It is down -0.03% in the last 24 hours and down -7.97% over the past month.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
See More
Previous Close:
$197.06
Open:
$197.71
24h Volume:
1.36M
Relative Volume:
0.77
Market Cap:
$46.14B
Revenue:
$250.74B
Net Income/Loss:
$1.55B
P/E Ratio:
30.12
EPS:
6.5398
Net Cash Flow:
$4.39B
1W Performance:
-4.19%
1M Performance:
-7.97%
6M Performance:
+0.11%
1Y Performance:
+29.61%
1-Day Range:
$195.01
$198.38
1-Week Range:
$185.80
$204.90
52-Week Range:
$137.75
$233.60
Cardinal Health Inc Stock (CAH) Company Profile
Name
Cardinal Health Inc
Sector
Industry
Phone
(614) 757-3033
Address
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
197.00 | 46.15B | 250.74B | 1.55B | 4.39B | 6.5398 |
MCK
Mckesson Corp
|
801.01 | 98.95B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
305.90 | 59.07B | 325.78B | 1.64B | 3.61B | 8.3139 |
HSIC
Henry Schein Inc
|
74.37 | 8.26B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.20 | 1.83B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-05-25 | Upgrade | Jefferies | Hold → Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-06-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-13-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Upgrade | Argus | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Underweight |
| Jul-10-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-23 | Initiated | Citigroup | Neutral |
| Feb-03-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-04-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| May-26-22 | Downgrade | Barclays | Overweight → Equal Weight |
| May-18-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Apr-12-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Aug-06-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Underperform |
| May-10-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-21 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-25-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Jul-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-20-20 | Upgrade | BofA/Merrill | Underperform → Buy |
| Feb-12-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-16-19 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-27-19 | Downgrade | Argus | Buy → Hold |
| Aug-20-19 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-18-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-16-18 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Apr-02-18 | Upgrade | Argus | Hold → Buy |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Underperform |
| Jan-05-18 | Initiated | Evercore ISI | In-line |
View All
Cardinal Health Inc Stock (CAH) Latest News
Cardinal Health raises quarterly dividend to $0.5158 per share By Investing.com - Investing.com Canada
Cardinal Health Board of Directors Approves Quarterly Dividend - Cardinal Health
Cardinal Health (CAH) Valuation Check After Strong Long Term Shareholder Returns - Yahoo Finance
Cardinal Health Momentum Builds Across NYSE Composite - Kalkine Media
Jim Cramer on Cardinal: “Gotta Put That One Behind” - Insider Monkey
Is It Time To Reassess Cardinal Health (CAH) After Its Strong Multi Year Rally? - Sahm
US Bancorp DE Purchases 12,955 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Kornitzer Capital Management Inc. KS Buys 9,120 Shares of Cardinal Health, Inc. $CAH - MarketBeat
PFA Pension Forsikringsaktieselskab Purchases Shares of 268,123 Cardinal Health, Inc. $CAH - MarketBeat
Cairn Investment Group Inc. Has $2.35 Million Stock Holdings in Cardinal Health, Inc. $CAH - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Cardinal Health Among 9 Companies To Announce Dividend Increases In The First Half Of May - Seeking Alpha
Cardinal Health, Inc. $CAH Shares Sold by LMG Wealth Partners LLC - MarketBeat
CAH Q1 Deep Dive: Specialty Growth, Tariff Dynamics, and Margin Pressures Shape Cardinal Health’s Outlook - Yahoo Finance
Cardinal Health, Inc. $CAH Shares Sold by Danske Bank A S - MarketBeat
MSN Money - MSN
Here's why you should add Cardinal Health stock to your portfolio now - MSN
Caisse Des Depots ET Consignations Has $5.51 Million Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health, Inc. $CAH Stock Holdings Lifted by Artemis Investment Management LLP - MarketBeat
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cardinal Health (CAH) and Illumina (ILMN) - The Globe and Mail
Cardinal Health Lifts 2026 Outlook After Strong Q3 - The Globe and Mail
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health (CAH) Is Down 5.8% After Mixed Q3 2026 Beat And Higher Earnings Guidance - Yahoo Finance
Wells Fargo Adjusts Price Target on Cardinal Health to $245 From $256 - marketscreener.com
Baird Adjusts Price Target on Cardinal Health to $248 From $257 - marketscreener.com
Citigroup Adjusts Price Target on Cardinal Health to $245 From $249 - marketscreener.com
A Quick Look at Today's Ratings for Cardinal Health(CAH.US), With a Forecast Between $240 to $258 - Moomoo
Cardinal Health Inc (CAH) Q3 2026 Earnings Call Highlights: Stro - GuruFocus
Cardinal Health Q3 FY26 slides: EPS beats, guidance raised amid tariff headwinds By Investing.com - Investing.com South Africa
Cardinal Health Q3 Earnings Call Highlights - Yahoo Finance
Kimberly Patterson Appointed as Director, Human Resources Business Partner at Cardinal Health - hrtoday.in
Cardinal Health Q3 2026 earnings preview - MSN
Cardinal Health Q3 2026 Financial Results: Revenue Growth Driven by Pharmaceutical and Specialty Solutions Segment - Minichart
Cardinal Health Inc (CAH) Shares Fall 4.9% -- What GF Score of 8 - GuruFocus
Cardinal Health, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Cardinal Health Is One of the S&P 500’s Biggest Decliners Today. A Guidance Hike Didn’t Matter. - Barron's
Cardinal Health lifts annual profit forecast on strong demand for specialty drugs - marketscreener.com
Stock Market Today: Dow Jones Roars As Industrials Rescue Wall Street From Meta-Led Tech Slide - Benzinga
Cardinal Health Releases Q3 2026 Financial Results - AlphaStreet
CAH Gains on Q3 Earnings Beat, '26 EPS View Up Despite Revenue Miss - Yahoo Finance UK
Cardinal's Growth Momentum Looks Strong From Prescription Trends, Specialty Investments, and GLP-1s - Morningstar
Cardinal Health's revenue miss clouds annual profit forecast raise - Reuters
Cardinal Health Q3 FY26 slides: EPS beats, guidance raised amid tariff headwinds - Investing.com India
Cardinal Health (CAH) Adjusts Financial Outlook for FY26 - GuruFocus
Why Is Cardinal Health Stock Sinking Thursday? - Benzinga
Earnings call transcript: Cardinal Health Q3 2026 beats EPS estimates but revenue misses - Investing.com
Is Cardinal Health (CAH) Overvalued After Q3 FY26 Earnings? Adj. - GuruFocus
Cardinal Health, Inc. 2026 Q3ResultsEarnings Call Presentation (NYSE:CAH) 2026-04-30 - Seeking Alpha
Cardinal Health (CAH) Reports Q3 Earnings, Raises FY26 EPS Guida - GuruFocus
Cardinal Health lifts profit forecast on demand for specialty drugs - WTVB
Cardinal Health (CAH) Stock Rises on Upgraded Full-Year Earnings Forecast Despite Revenue Shortfall - Blockonomi
Cardinal Health Inc Stock (CAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):